NRXS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Neuraxis Inc (NRXS) is not a strong buy at this time for a beginner investor with a long-term focus. While the company's recent financial performance shows revenue growth and a narrower net loss, the technical indicators are neutral, and there is no strong trading signal or positive news catalyst. Additionally, the stock's short-term trend suggests potential downside, making it less appealing for immediate investment.
The MACD is below 0 and negatively contracting, indicating weak momentum. RSI is neutral at 55.93, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Support is at 6.613, and resistance is at 7.782. Overall, the technical indicators do not provide a strong buy signal.
Analyst Chase Knickerbocker raised the price target to $13 from $8, citing better-than-expected Q1 results and positive management commentary on early 2026 trends.
The stock has a 70% chance of declining in the next day (-3.02%), week (-4.31%), and month (-6.93%). No recent news or significant trading trends from hedge funds or insiders.
In Q4 2025, revenue increased by 27.19% YoY to $968,127, and net income improved by 14.73% YoY to -$1,903,539. However, EPS dropped by -21.74% YoY to -0.18, and gross margin slightly declined to 85.37%.
Craig-Hallum analyst maintains a Buy rating and raised the price target to $13, citing strong Q1 results and positive early 2026 trends.
